Lista de obras -

Are Researchers Willing to Share Their Published Manuscript?

artículo científico publicado en 2018

Assessing complete remission status in incurable follicular lymphomas, to what purpose?

artículo científico publicado en 2018

Bone marrow 18F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography cannot replace bone marrow biopsy in diffuse large B-cell lymphoma

artículo científico publicado en 2014

Bone marrow FDG-PET/CT in Hodgkin lymphoma revisited: do imaging and pathology match?

artículo científico publicado en 2014

Bone marrow biopsy in diffuse large B-cell lymphoma: useful or redundant test?

artículo científico publicado en 2014

CT-based versus FDG-PET/CT-based NCCN international prognostic index risk stratification in DLBCL.

artículo científico publicado en 2015

Chest CT in Patients with COVID-19: Toward a Better Appreciation of Study Results and Clinical Applicability

artículo científico publicado en 2020

Diagnostic Performance of CO-RADS and the RSNA Classification System in Evaluating COVID-19 at Chest CT: A Meta-Analysis

artículo científico publicado en 2021

Diagnostic value of MRI signs in differentiating Ewing sarcoma from osteomyelitis

scientific article published on 09 May 2018

Diffusely increased bone marrow FDG uptake in recently untreated lymphoma: incidence and relevance

artículo científico publicado en 2015

Direct comparison of visual and quantitative bone marrow FDG-PET/CT findings with bone marrow biopsy results in diffuse large B-cell lymphoma: does bone marrow FDG-PET/CT live up to its promise?

artículo científico publicado en 2014

Does the presence of tumor-induced cortical bone destruction at CT have any prognostic value in newly diagnosed diffuse large B-cell lymphoma?

artículo científico publicado en 2015

Effect of blind bone marrow biopsy on FDG-PET/CT interpretation of the posterior iliac crest in diffuse large B-cell lymphoma

scientific article published on 10 October 2014

FDG PET/CT for the detection of bone marrow involvement in diffuse large B-cell lymphoma: systematic review and meta-analysis

artículo científico publicado en 2013

False-negative FDG-PET in histologically proven extensive large cell bone marrow involvement in diffuse large B-cell lymphoma

artículo científico publicado en 2015

Interim FDG-PET does not predict outcome in advanced-stage Hodgkin lymphoma patients treated with BEACOPP

scientific article published on 14 November 2018

Interim FDG-PET has no value in selecting patients who require treatment modification in both early- and advanced-stage Hodgkin lymphoma.

artículo científico publicado en 2017

Interim FDG-PET in lymphoma, a questionable practice in hematology.

artículo científico publicado en 2017

Lymphoma grading with FDG-PET/CT readdressed: Direct and timely histopathological correlation study

artículo científico publicado en 2015

Opportunities and limitations of bone marrow biopsy and bone marrow FDG-PET in lymphoma

artículo científico

Outcome of Hodgkin Lymphoma Patients With a Posttreatment 18F-Fluoro-2-Deoxy-d-Glucose Positron Emission Tomography (FDG-PET)-Negative Residual Mass: Systematic Review and Meta-analysis

artículo científico publicado en 2015

Paget's disease of the bone mimicking lymphomatous bone marrow involvement at FDG-PET.

artículo científico publicado en 2015

Post-ABVD biopsy results, and not post-ABVD FDG-PET results, predict outcome in early-stage Hodgkin lymphoma

artículo científico publicado en 2017

Potential prognostic implications of whole-body bone marrow MRI in diffuse large B-cell lymphoma patients with a negative blind bone marrow biopsy

artículo científico publicado en 2013

Prognostic Value of Anemia and C-Reactive Protein Levels in Diffuse Large B-Cell Lymphoma

artículo científico publicado en 2015

Prognostic implications of imaging-based bone marrow assessment in lymphoma: 18F-FDG PET, MR imaging, or 18F-FDG PET/MR imaging?

artículo científico publicado en 2013

Prognostic superiority of the National Comprehensive Cancer Network International Prognostic Index over pretreatment whole-body volumetric-metabolic FDG-PET/CT metrics in diffuse large B-cell lymphoma

artículo científico publicado en 2015

Prognostic value of complete remission status at end-of-treatment FDG-PET in R-CHOP-treated diffuse large B-cell lymphoma: systematic review and meta-analysis

artículo científico

Prognostic value of interim FDG-PET in Hodgkin lymphoma: systematic review and meta-analysis

artículo científico

Prognostic value of interim and end-of-treatment FDG-PET in follicular lymphoma: a systematic review

artículo científico publicado en 2016

Prognostic value of tumor necrosis at CT in diffuse large B-cell lymphoma

artículo científico publicado en 2014

Residual Anatomical Disease in Diffuse Large B-Cell Lymphoma Patients With FDG-PET-Based Complete Response After First-Line R-CHOP Therapy: Does It Have Any Prognostic Value?

artículo científico publicado en 2015

Systematic Review on the Additional Value of 18F-Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography in Staging Follicular Lymphoma

artículo científico publicado en 2016

Systematic review and meta-analysis on the prognostic value of complete remission status at FDG-PET in Hodgkin lymphoma after completion of first-line therapy

artículo científico publicado en 2016

Systematic review on the value of end-of-treatment FDG-PET in improving overall survival of lymphoma patients

scientific article published on 07 December 2019

Tumor necrosis at FDG-PET is an independent predictor of outcome in diffuse large B-cell lymphoma

artículo científico publicado en 2015

Unproven value of end-of-treatment FDG-PET in Hodgkin lymphoma.

artículo científico publicado en 2017

Utility of quantitative FDG-PET/CT for the detection of bone marrow involvement in follicular lymphoma: a histopathological correlation study

artículo científico publicado en 2014

Value of detecting bone marrow involvement in Hodgkin lymphoma

artículo científico publicado en 2019

Variety in bone marrow 18F-FDG uptake in Hodgkin lymphoma patients without lymphomatous bone marrow involvement: does it have an explanation?

artículo científico publicado en 2015

Where Does Diffuse Large B-Cell Lymphoma Relapse?

artículo científico publicado en 2016

Whole-body MRI for the detection of bone marrow involvement in lymphoma: prospective study in 116 patients and comparison with FDG-PET.

artículo científico publicado en 2013

Whole-body MRI vs. CT for staging lymphoma: patient experience

artículo científico publicado en 2013

Lista de obras de

Are Researchers Willing to Share Their Published Manuscript?

Assessing complete remission status in incurable follicular lymphomas, to what purpose?

Bone marrow 18F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography cannot replace bone marrow biopsy in diffuse large B-cell lymphoma

Bone marrow FDG-PET/CT in Hodgkin lymphoma revisited: do imaging and pathology match?

Bone marrow biopsy in diffuse large B-cell lymphoma: useful or redundant test?

CT-based versus FDG-PET/CT-based NCCN international prognostic index risk stratification in DLBCL.

Chest CT in Patients with COVID-19: Toward a Better Appreciation of Study Results and Clinical Applicability

Diagnostic Performance of CO-RADS and the RSNA Classification System in Evaluating COVID-19 at Chest CT: A Meta-Analysis

Diagnostic value of MRI signs in differentiating Ewing sarcoma from osteomyelitis

Diffusely increased bone marrow FDG uptake in recently untreated lymphoma: incidence and relevance

Direct comparison of visual and quantitative bone marrow FDG-PET/CT findings with bone marrow biopsy results in diffuse large B-cell lymphoma: does bone marrow FDG-PET/CT live up to its promise?

Does the presence of tumor-induced cortical bone destruction at CT have any prognostic value in newly diagnosed diffuse large B-cell lymphoma?

Effect of blind bone marrow biopsy on FDG-PET/CT interpretation of the posterior iliac crest in diffuse large B-cell lymphoma

FDG PET/CT for the detection of bone marrow involvement in diffuse large B-cell lymphoma: systematic review and meta-analysis

False-negative FDG-PET in histologically proven extensive large cell bone marrow involvement in diffuse large B-cell lymphoma

Interim FDG-PET does not predict outcome in advanced-stage Hodgkin lymphoma patients treated with BEACOPP

Interim FDG-PET has no value in selecting patients who require treatment modification in both early- and advanced-stage Hodgkin lymphoma.

Interim FDG-PET in lymphoma, a questionable practice in hematology.

Lymphoma grading with FDG-PET/CT readdressed: Direct and timely histopathological correlation study

Opportunities and limitations of bone marrow biopsy and bone marrow FDG-PET in lymphoma

Outcome of Hodgkin Lymphoma Patients With a Posttreatment 18F-Fluoro-2-Deoxy-d-Glucose Positron Emission Tomography (FDG-PET)-Negative Residual Mass: Systematic Review and Meta-analysis

Paget's disease of the bone mimicking lymphomatous bone marrow involvement at FDG-PET.

Post-ABVD biopsy results, and not post-ABVD FDG-PET results, predict outcome in early-stage Hodgkin lymphoma

Potential prognostic implications of whole-body bone marrow MRI in diffuse large B-cell lymphoma patients with a negative blind bone marrow biopsy

Prognostic Value of Anemia and C-Reactive Protein Levels in Diffuse Large B-Cell Lymphoma

Prognostic implications of imaging-based bone marrow assessment in lymphoma: 18F-FDG PET, MR imaging, or 18F-FDG PET/MR imaging?

Prognostic superiority of the National Comprehensive Cancer Network International Prognostic Index over pretreatment whole-body volumetric-metabolic FDG-PET/CT metrics in diffuse large B-cell lymphoma

Prognostic value of complete remission status at end-of-treatment FDG-PET in R-CHOP-treated diffuse large B-cell lymphoma: systematic review and meta-analysis

Prognostic value of interim FDG-PET in Hodgkin lymphoma: systematic review and meta-analysis

Prognostic value of interim and end-of-treatment FDG-PET in follicular lymphoma: a systematic review

Prognostic value of tumor necrosis at CT in diffuse large B-cell lymphoma

Residual Anatomical Disease in Diffuse Large B-Cell Lymphoma Patients With FDG-PET-Based Complete Response After First-Line R-CHOP Therapy: Does It Have Any Prognostic Value?

Systematic Review on the Additional Value of 18F-Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography in Staging Follicular Lymphoma

Systematic review and meta-analysis on the prognostic value of complete remission status at FDG-PET in Hodgkin lymphoma after completion of first-line therapy

Systematic review on the value of end-of-treatment FDG-PET in improving overall survival of lymphoma patients

Tumor necrosis at FDG-PET is an independent predictor of outcome in diffuse large B-cell lymphoma

Unproven value of end-of-treatment FDG-PET in Hodgkin lymphoma.

Utility of quantitative FDG-PET/CT for the detection of bone marrow involvement in follicular lymphoma: a histopathological correlation study

Value of detecting bone marrow involvement in Hodgkin lymphoma

Variety in bone marrow 18F-FDG uptake in Hodgkin lymphoma patients without lymphomatous bone marrow involvement: does it have an explanation?

Where Does Diffuse Large B-Cell Lymphoma Relapse?

Whole-body MRI for the detection of bone marrow involvement in lymphoma: prospective study in 116 patients and comparison with FDG-PET.

Whole-body MRI vs. CT for staging lymphoma: patient experience